Medicine, Hematology Oncology Division

Fingerprint Dive into the research topics where Medicine, Hematology Oncology Division is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.

Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Survival Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Prostatic Neoplasms Medicine & Life Sciences
Acute Myeloid Leukemia Medicine & Life Sciences
Leukemia, Myelogenous, Chronic, BCR-ABL Positive Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Profiles

No photo of Kehinde Adekola

Kehinde Adekola

Person: Academic

20122023
No photo of Mark Agulnik

Mark Agulnik

Person: Academic

20012024
No photo of Jessica K Altman

Jessica K Altman

Person: Academic

20052024

Research Output 1956 2020

BMI1 is directly regulated by androgen receptor to promote castration-resistance in prostate cancer

Zhu, S., Zhao, D., Li, C., Li, Q., Jiang, W., Liu, Q., Wang, R., Fazli, L., Li, Y., Zhang, L., Yi, Y., Meng, Q., Wang, W., Wang, G., Zhang, M., Zu, X., Zhao, W., Deng, T., Yu, J., Dong, X. & 2 others, Chen, K. & Cao, Q., Jan 2 2020, In : Oncogene. 39, 1, p. 17-29 13 p.

Research output: Contribution to journal › Article

Castration
Androgen Receptors
Lymphoma
Prostatic Neoplasms
Neoplasms

Corrigendum to “Efficacy + safety of palbociclib (P) in patients (pts) ≤50 y with hormone receptor‒positive (HR+)/human epidermal growth factor receptor 2‒negative (HER2–) advanced breast cancer (ABC): Subgroup analysis of 2 randomized phase 3 studies” (The Breast (2018) 41(S1) (S11–S12), (S0960977618301760), (10.1016/j.breast.2018.08.033))

Cristofanilli, M., Harbeck, N., Rugo, H. S., Castrellon, A., Joy, A. A., Verma, S., Im, S. A., Iyer, S., Puyana Theall, K., Gauthier, E., Huang, X., Bartlett, C. H., Loibl, S. & Finn, R. S., Feb 2020, In : Breast. 49, 1 p.

Research output: Contribution to journal › Comment/debate

Open Access
Epidermal Growth Factor Receptor
Names
Breast
Hormones
Breast Neoplasms

Educational Material on Prostate Cancer Screening is Overly Complex and Fails to Meet Recommended Layperson Readability Guidelines

Rooney, M. K., Morgans, A. K., Chen, R. C., Golden, D. W., Meeks, J. J., Auffenberg, G., Kundu, S. D., Schaeffer, E. M., Hussain, M. H., Kalapurakal, J. A. & Sachdev, S., Jan 2020, In : Urology. 135, p. 1-3 3 p.

Research output: Contribution to journal › Editorial

Grants 1996 2027

Prot #CPI-006-001: A Phase 1/1b Multicenter Study To Evaluate The Humanized Anti-CD73 Antibody, CPI-006, As A Single Agent or In Combination With Ciforadenant, with Pembrolizumab, And With Ciforadenant Plus Pembrolizumab In Adult Subjects With Advanced Ca

Sosman, J. A.

Corvus Pharmaceuticals, Inc.

12/20/19 → 12/20/22

Project: Research project

Prot #D9103C00001: A Phase III, Randomized, Placebo-controlled, Double-blind, Multi-center, International Study of Durvalumab Following Stereotactic Body Radiation Therapy (SBRT) for the Treatment of Patients with Unresected Stage I/II Lymph-node Negative

Mohindra, N. A.

AstraZeneca Pharmaceuticals LP

12/20/19 → 12/20/22

Project: Research project

Prot #7465-CL-0108: A Multicenter, Open-label, Expanded Access Treatment Protocol of Enfortumab Vedotin in Subjects with Locally Advanced or Metastatic Urothelial Carcinoma (EV-901)

Morgans, A. K.

Parexel, Astellas Pharma Global Development, Inc.

12/17/19 → 12/17/22

Project: Research project